Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Pediatr Blood Cancer. 2009 Sep;53(3):401–405. doi: 10.1002/pbc.22048

Table III.

Opioid-Induced Adverse Events in the First Six-Months of the Intervention Compared to the Same Seasonal Time Period in the Previous Year

Adverse Event Intervention
Cohort
n=89
Control
Cohort
n=85
p-value

Dose reduction for:
 Excessive Sedation 3 (3%) 5 (6%) 0.50
 Decreased Oxygen 2 (2%) 0 0.50
Saturations 2 (3%) 0 0.50
 Respiratory Depression

Naloxone Administration 1 0 1

Nausea 25 (28%) 20 (24%) 0.60

Pruritis 58 (56%) 58 (68%) 0.75